To clarify the effect of cilnidipine, a long-acting dihydropyridine Ca-antagonist that blocks both L-and Ntype Ca 2 -channels, on insulin sensitivity, cilnidipine at 5 to 10 mg/day was administered to ten patients with essential hypertension for 12 weeks. Mean age and body mass index (BMI) were 57.